Literature DB >> 21131470

Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans.

Elena N Atochina-Vasserman1, Carla Winkler, Helen Abramova, Frank Schaumann, Norbert Krug, Andrew J Gow, Michael F Beers, Jens M Hohlfeld.   

Abstract

RATIONALE: Surfactant protein D (SP-D), a 43-kD collectin, is synthesized and secreted by airway epithelia as a dodecamer formed by assembly of four trimeric subunits. We have previously shown that the quaternary structure of SP-D can be altered during inflammatory lung injury through its modification by S-nitrosylation, which in turn alters its functional behavior producing a proinflammatory response in effector cells.
OBJECTIVES: We hypothesized that alterations in structure and function of SP-D may occur in humans with acute allergic inflammation.
METHODS: Bronchoalveolar lavage (BAL) fluid was collected from 15 nonsmoking patients with mild intermittent allergic asthma before and 24 hours after segmental provocation with saline, allergen, LPS, and mixtures of allergen and LPS. Structural modifications of SP-D were analyzed by native and sodium dodecyl sulfate gel electrophoresis.
MEASUREMENTS AND MAIN RESULTS: The multimeric structure of native SP-D was found to be disrupted after provocation with allergen or a mixture of allergen and LPS. Interestingly, under reducing conditions, sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated that 7 of 15 patients with asthma developed an abnormal cross-linked SP-D band after segmental challenge with either allergen or a mixture of allergen with LPS but not LPS alone. Importantly, patients with asthma with cross-linked SP-D demonstrated significantly higher levels of BAL eosinophils, nitrogen oxides, IL-4, IL-5, IL-13, and S-nitrosothiol-SP-D compared with patients without cross-linked SP-D.
CONCLUSIONS: We conclude that segmental allergen challenge results in changes of SP-D multimeric structure and that these modifications are associated with an altered local inflammatory response in the distal airways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131470      PMCID: PMC3086753          DOI: 10.1164/rccm.201004-0654OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  38 in total

1.  Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma.

Authors:  V J Erpenbeck; R Schmidt; A Günther; N Krug; J M Hohlfeld
Journal:  Allergy       Date:  2006-05       Impact factor: 13.146

2.  Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse.

Authors:  C J Wong; J Akiyama; L Allen; S Hawgood
Journal:  Pediatr Res       Date:  1996-06       Impact factor: 3.756

3.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.

Authors:  S E Wert; M Yoshida; A M LeVine; M Ikegami; T Jones; G F Ross; J H Fisher; T R Korfhagen; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species.

Authors:  J C MacPherson; S A Comhair; S C Erzurum; D F Klein; M F Lipscomb; M S Kavuru; M K Samoszuk; S L Hazen
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

5.  Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D.

Authors:  Paul S Kingma; Liqian Zhang; Machiko Ikegami; Kevan Hartshorn; Francis X McCormack; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

6.  Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.

Authors:  A M LeVine; J A Whitsett; K L Hartshorn; E C Crouch; T R Korfhagen
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

7.  Expired nitric oxide as a marker for childhood asthma.

Authors:  B V Nelson; S Sears; J Woods; C Y Ling; J Hunt; L M Clapper; B Gaston
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

8.  Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation.

Authors:  Elena N Atochina-Vasserman; Andrew J Gow; Helen Abramova; Chang-Jiang Guo; Yaniv Tomer; Angela M Preston; James M Beck; Michael F Beers
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Ida Tornoe; Grith L Sorensen; Erika C Crouch; Uffe Holmskov
Journal:  Respir Res       Date:  2007-02-05

10.  S-nitrosylation of surfactant protein-D controls inflammatory function.

Authors:  Chang-Jiang Guo; Elena N Atochina-Vasserman; Elena Abramova; Joseph P Foley; Aisha Zaman; Erika Crouch; Michael F Beers; Rashmin C Savani; Andrew J Gow
Journal:  PLoS Biol       Date:  2008-11-11       Impact factor: 8.029

View more
  18 in total

Review 1.  Update in asthma 2011.

Authors:  Shamsah Kazani; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2012-07-01       Impact factor: 21.405

2.  Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation.

Authors:  Shida Yousefi; Satish K Sharma; Darko Stojkov; Nina Germic; Salome Aeschlimann; Moyar Q Ge; Cameron H Flayer; Erik D Larson; Imre G Redai; Suhong Zhang; Cynthia J Koziol-White; Katalin Karikó; Hans-Uwe Simon; Angela Haczku
Journal:  J Leukoc Biol       Date:  2018-05-07       Impact factor: 4.962

3.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

Review 4.  S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation.

Authors:  Elena N Atochina-Vasserman
Journal:  Biochim Biophys Acta       Date:  2011-12-13

5.  IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M.

Authors:  Qun Wu; Di Jiang; Sean Smith; Jyoti Thaikoottathil; Richard J Martin; Russell P Bowler; Hong Wei Chu
Journal:  J Allergy Clin Immunol       Date:  2011-12-09       Impact factor: 10.793

6.  Surfactant protein-D modulation of pulmonary macrophage phenotype is controlled by S-nitrosylation.

Authors:  Chang-Jiang Guo; Elena N Atochina-Vasserman; Elena Abramova; Ley Cody Smith; Michael F Beers; Andrew J Gow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-14       Impact factor: 5.464

7.  Radiation-induced lung injury and inflammation in mice: role of inducible nitric oxide synthase and surfactant protein D.

Authors:  Rama Malaviya; Andrew J Gow; Mary Francis; Elena V Abramova; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Sci       Date:  2014-12-30       Impact factor: 4.849

Review 8.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

9.  SNObase, a database for S-nitrosation modification.

Authors:  Xu Zhang; Bo Huang; Lunfeng Zhang; Yuying Zhang; Yingying Zhao; Xiaofei Guo; Xinhua Qiao; Chang Chen
Journal:  Protein Cell       Date:  2012-11-06       Impact factor: 14.870

10.  Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis.

Authors:  Stephanie M Holmer; Kathy S Evans; Yohannes G Asfaw; Divey Saini; Wiley A Schell; Julie G Ledford; Richard Frothingham; Jo Rae Wright; Gregory D Sempowski; John R Perfect
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.